Vol 2011, No 7 (2011)

Table of Contents

Research & Development

Genentech Gain Rights to Acquire Forma Therapeutics’ Preclinical Cancer Programme in Innovative Deal Abstract
Heather Cartwright
AstraZeneca and PTC Therapeutics Sign Cancer Drug Discovery Pact Abstract
Heather Cartwright
Rib-X Pharmaceuticals Signs Global Antibiotic Research Collaboration with Sanofi Abstract
Heather Cartwright
Micromet Signs US$1 B BiTE® Antibody Collaboration with Amgen Abstract
Heather Cartwright

Licensing

Gilead and Tibotec Partner to Develop and Commercialise HIV Combination Drugs Abstract
Heather Cartwright
BMS Licenses Innate Pharma’s Phase I Immuno-Oncology Monoclonal Antibody Abstract
Heather Cartwright

Mergers & Acquisitions

Allozyne to Go Public via Reverse Merger with Poniard Pharmaceuticals Abstract
Heather Cartwright
Valeant to Buy Sanofi’s Dermik Skincare Unit for US$425 M Abstract
Heather Cartwright
Valeant Continues its Acquisition Spree with Agreement to Buy Janssen’s Ortho Dermatologics Division Abstract
Heather Cartwright
Allergan Agrees to Acquire Vicept Therapeutics in US$275 M Deal Abstract
Heather Cartwright
Roche Broadens its Cancer Diagnostics Portfolio with mtm laboratories Acquisition Abstract
Heather Cartwright

Cartoons

Hardball Abstract jpg
Clive Goddard

Royalties

Astellas Divests Prosidion’s DPP-IV Inhibitor Patent Assets to Royalty Pharma Abstract
Heather Cartwright


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.